USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)
Close on Nov 17, 2026Market cap $250.73MP/E –Yield –
USANA Health Sciences cash
Cash and short-term investments held at the end of each period.
USANA Health Sciences's cash was $168.56M at Jul 4, 2026. For fiscal 2025 it was $158.38M, down 12.9% from the year before. Over ten years it grew 0.8% a year on average. The highest annual figure on record is $330.42M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $158.38M | -12.9% |
| FY2024 | Dec 28, 2024 | $181.77M | -45.0% |
| FY2023 | Dec 30, 2023 | $330.42M | +14.6% |
| FY2022 | Dec 31, 2022 | $288.42M | +20.3% |
| FY2021 | Jan 1, 2022 | $239.83M | -23.1% |
| FY2020 | Jan 2, 2021 | $311.92M | +32.8% |
| FY2019 | Dec 28, 2019 | $234.83M | +9.6% |
| FY2018 | Dec 29, 2018 | $214.33M | -13.3% |
| FY2017 | Dec 30, 2017 | $247.13M | +38.1% |
| FY2016 | Dec 31, 2016 | $178.95M | +22.0% |
| FY2015 | Jan 2, 2016 | $146.73M | +32.0% |
| FY2014 | Jan 3, 2015 | $111.13M | -19.1% |
| FY2013 | Dec 28, 2013 | $137.34M | +93.9% |
| FY2012 | Dec 29, 2012 | $70.84M | +40.7% |
| FY2011 | Dec 31, 2011 | $50.35M | 0.0% |
| FY2010 | Jan 1, 2011 | $50.35M | +268.7% |
| FY2009 | Jan 2, 2010 | $13.66M | +2.8% |
| FY2008 | Jan 3, 2009 | $13.28M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 4, 2026 | $168.56M | +11.4% |
| Q1 FY2026 | Apr 4, 2026 | $162.75M | -9.4% |
| Q4 FY2025 | Jan 3, 2026 | $158.38M | -12.9% |
| Q3 FY2025 | Sep 27, 2025 | $145.35M | -60.2% |
| Q2 FY2025 | Jun 28, 2025 | $151.34M | -54.5% |
| Q1 FY2025 | Mar 29, 2025 | $179.61M | -45.3% |
| Q4 FY2024 | Dec 28, 2024 | $181.77M | -45.0% |
| Q3 FY2024 | Sep 28, 2024 | $364.89M | +18.8% |
| Q2 FY2024 | Jun 29, 2024 | $332.42M | +10.7% |
| Q1 FY2024 | Mar 30, 2024 | $328.34M | +11.1% |
| Q4 FY2023 | Dec 30, 2023 | $330.42M | +14.6% |
| Q3 FY2023 | Sep 30, 2023 | $307.08M | +24.4% |
| Q2 FY2023 | Jul 1, 2023 | $300.18M | +30.3% |
| Q1 FY2023 | Apr 1, 2023 | $295.45M | +24.3% |
| Q4 FY2022 | Dec 31, 2022 | $288.42M | +20.3% |
| Q3 FY2022 | Oct 1, 2022 | $246.88M | -0.7% |
| Q2 FY2022 | Jul 2, 2022 | $230.37M | -13.2% |
| Q1 FY2022 | Apr 2, 2022 | $237.75M | -7.5% |
| Q4 FY2021 | Jan 1, 2022 | $239.83M | -23.1% |
| Q3 FY2021 | Oct 2, 2021 | $248.70M | -10.7% |
| Q2 FY2021 | Jul 3, 2021 | $265.37M | +16.7% |
| Q1 FY2021 | Apr 3, 2021 | $256.96M | +32.4% |
| Q4 FY2020 | Jan 2, 2021 | $311.92M | +32.8% |
| Q3 FY2020 | Sep 26, 2020 | $278.42M | +52.4% |
| Q2 FY2020 | Jun 27, 2020 | $227.37M | -1.7% |
| Q1 FY2020 | Mar 28, 2020 | $194.10M | -13.7% |
| Q4 FY2019 | Dec 28, 2019 | $234.83M | +9.6% |
| Q3 FY2019 | Sep 28, 2019 | $182.75M | -23.8% |
| Q2 FY2019 | Jun 29, 2019 | $231.35M | -9.7% |
| Q1 FY2019 | Mar 30, 2019 | $225.04M | -15.5% |
| Q4 FY2018 | Dec 29, 2018 | $214.33M | -13.3% |
| Q3 FY2018 | Sep 29, 2018 | $239.75M | +25.0% |
| Q2 FY2018 | Jun 30, 2018 | $256.33M | +11.8% |
| Q1 FY2018 | Mar 31, 2018 | $266.20M | +51.0% |
| Q4 FY2017 | Dec 30, 2017 | $247.13M | +38.1% |
| Q3 FY2017 | Sep 30, 2017 | $191.75M | +42.5% |
| Q2 FY2017 | Jul 1, 2017 | $229.37M | – |
| Q1 FY2017 | Apr 1, 2017 | $176.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $178.95M | – |
| Q3 FY2016 | Oct 1, 2016 | $134.54M | – |
See a number that looks wrong?